Sangamo BioSciences | SGMO - Market Capitalization


Sangamo BioSciences reported $36.9M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 7M 2M Mar/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Alterity Therapeutics Limited AUD 39M 17M Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
Bayer EUR 48.39B 834.21M Aug/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Cipla INR 1.18T 194.93B Jun/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
CSL USD 60.19B 4.3B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 153.17B 14.73B Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
Vertex Pharmaceuticals USD 137.33B 11.26B Aug/2026